Announcements Trials

Browse Landscape

Phase

Status

Recruiting 7 Active not recruiting 5 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 1

Interventions

pembrolizumab 27 Cisplatin 17 Nivolumab 14 Cyclophosphamide 14 Carboplatin 13 Radiation 12 Paclitaxel 12 Doxorubicin 11 Radiotherapy 10 Radiotherapy, Intensity-Modulated 9 Cytarabine 9 Vincristine 8 Magnetic Resonance Spectroscopy 8 Docetaxel 8 Bevacizumab 8 Radiosurgery 7 Leucovorin 7 Fluorouracil 7 Etoposide 7 Specimen Handling 6 Prednisone 6 Pemetrexed 6 Irinotecan 6 Injections 6 Gemcitabine 6 Dexamethasone 6 venetoclax 5 tislelizumab 5 fludarabine 5 enzalutamide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × belzutifan × 30 days × Clear all

NCT04846920 2026-05-22

MK-6482-018

Merck Sharp & Dohme LLC

Phase 1 Completed

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡